Skip to main content

Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism.

Publication ,  Journal Article
Ara, G; Gravelin, LM; Kaddurah-Daouk, R; Teicher, BA
Published in: In Vivo
1998

When rats bearing the 13,762 mammary carcinoma were treated with intravenously administered creatine analogs, cyclocreatine, beta-guanidinopropionic acid or creatine phosphate on days 4 through 8 and 14 through 18 post tumor implantation, the tumor growth delay produced varied with whether the animals were drinking water or sugar water over the course of the study. The tumor growth delays increased when the animals drank sugar water from 9.3, 1.6 and 7.6 days for cyclocreatine, beta-guanidinopropionic acid and creatine phosphate, respectively, to 15.0, 6.3 and 12.6 days. Blood glucose was decreased over the course of the creatine analog treatment regimen and the skeletal muscle transport protein GLUT-4 increased 1.5 to 2-fold with the creatine analog treatments. Plasma insulin was profoundly decreased to 20-25% of normal by the creatine analog treatment while plasma glucagon levels were increased. Plasma somatostatin increased 3- to 4-fold during the administration of the creatine analogs. These results implicate alterations in pancreatic hormone balance in the antitumor activity of these creatine analogs.

Duke Scholars

Published In

In Vivo

ISSN

0258-851X

Publication Date

1998

Volume

12

Issue

2

Start / End Page

223 / 231

Location

Greece

Related Subject Headings

  • Tumor Cells, Cultured
  • Rats, Inbred F344
  • Rats
  • Propionates
  • Phosphocreatine
  • Pancreatic Hormones
  • Oncology & Carcinogenesis
  • Mammary Neoplasms, Experimental
  • Injections, Intravenous
  • Guanidines
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ara, G., Gravelin, L. M., Kaddurah-Daouk, R., & Teicher, B. A. (1998). Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism. In Vivo, 12(2), 223–231.
Ara, G., L. M. Gravelin, R. Kaddurah-Daouk, and B. A. Teicher. “Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism.In Vivo 12, no. 2 (1998): 223–31.
Ara G, Gravelin LM, Kaddurah-Daouk R, Teicher BA. Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism. In Vivo. 1998;12(2):223–31.
Ara G, Gravelin LM, Kaddurah-Daouk R, Teicher BA. Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism. In Vivo. 1998;12(2):223–231.

Published In

In Vivo

ISSN

0258-851X

Publication Date

1998

Volume

12

Issue

2

Start / End Page

223 / 231

Location

Greece

Related Subject Headings

  • Tumor Cells, Cultured
  • Rats, Inbred F344
  • Rats
  • Propionates
  • Phosphocreatine
  • Pancreatic Hormones
  • Oncology & Carcinogenesis
  • Mammary Neoplasms, Experimental
  • Injections, Intravenous
  • Guanidines